Papers by Tabassum Mohammad
FUTURE JOURNAL OF PHARMACEUTICALS AND HEALTH SCIENCES, 2022
Appraise the prescribing patterns of anti hypertensive agents in the treatmentof hypertension and... more Appraise the prescribing patterns of anti hypertensive agents in the treatmentof hypertension and related co-morbid conditions. To assess the prescribingpatterns of medications in hypertensive patients. To study the demograph-ics of patients associated with hypertension. To compare the differences inthe prescribing patterns of antihypertensive drugs, with co morbidity con-ditions. Review on medication outcomes in hypertensive patients. To eval-uate the rationality outcomes in hypertensive patients. To obtain the meanarterial blood pressure of an individual patient. The age group 40-69 hasmore affected females followed by males at age group 60-79. Blood pres-sure increases with age, presence of the co-morbid condition, body weight,and lifestyle modiβication. The cause of hypertension may be known in someindividuals whereas in most of the patients the cause is unknown. The indi-viduals must be made aware of hypertension and directions about manage-ment with drugs and non-pharmacological implementation. The presence ofhypertension for years may lead to further complications which if managedand monitored regularly can reduce risk. During the study period, 92 indi-viduals were stage 1 (36.8) hypertensive followed by stage 2 (29.6%), ele-vated (15.2%), and normal (9.6%). The most commonly prescribed drugs inthe study were Telmisartan (22.8%), Amlodipine (2.8%), Furosemide (2.4),Nifedipine (1.4), Captopril (1.4%), Metoprolol (0.8%), and Torsemide (0.8%)followed by losartan, Olmesartan, propranolol, ramipril, terlipressin, atenolol,valsartan, carvedilol, mannitol, vasopressin, and bisoprolol. Based on JNC 8guideline the rationality of drugs obtained was 74.8%.
Uploads
Papers by Tabassum Mohammad